Clinical trials
Recruiting Observational Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 10 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 12 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jinling Hospital, China | 3 |
| IRCCS San Raffaele | 2 |
| National Cancer Institute (NCI) | 2 |
| Peking University First Hospital | 2 |
| Peking University Third Hospital | 2 |
| Shao Pengfei | 2 |
| Yonsei University | 2 |
| A2 Biotherapeutics Inc. | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 54 |
| Kidney Neoplasms | 16 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Urinary Bladder Neoplasms | 7 |
| Melanoma | 6 |
| Carcinoma, Hepatocellular | 5 |
| Carcinoma, Transitional Cell | 5 |
| Esophageal Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.